PharmD Info

A forum for Indian Pharmacy Professionals

New Drug Information's and other safety information, drug label changes, and Dose and Dosage Calculations, CDCSO,PvPI and FDA Safety Alerts and etc.
Forum rules: The material, content provided by this forum is for informational purpose only and is not intended for substitute to medical advice, diagnosis or treatment.General rules are applicable for this forum- Find Here
  • User avatar
#3288
CDER Drug Safety Priorities 2018 outlines the breadth of safety activities of CDER and offers reports on the safety-related accomplishments and milestones of the year.

CDER Drug Safety Priorities 2018 provides a snapshot of several of our important drug safety programs and initiatives and explains the comprehensive and collaborative essence of our safety work as expressed in some of the key safety-related accomplishments and achievements of the year.

To download the Report - Click Here
Attachments:
Drug safety priorities 2018 .jpg
Drug safety priorities 2018 .jpg (23.67 KiB) Viewed 2230 times
Similar Topics
Topics Statistics Last post
0 Replies 
1160 Views
by Admin
0 Replies 
1313 Views
by Admin
0 Replies 
1180 Views
by Admin
0 Replies 
528 Views
by Admin
0 Replies 
1394 Views
by Admin

Tamoxifen remains active for up to two weeks after[…]

Pharmacy practice in India is a dynamic and rapidl[…]

PBMs, or Pharmacy Benefit Managers, are businesses[…]

Banocide forte is an anthelmintic medication prim[…]

PharmD Info - Highlights